- Home
- CHRW vs SNN Comparison
CHRW vs SNN Comparison
Compare CHRW & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRW
- SNN
- Stock Information
- Founded
- CHRW 1905
- SNN 1856
- Country
- CHRW United States
- SNN United Kingdom
- Employees
- CHRW N/A
- SNN N/A
- Industry
- CHRW Oil Refining/Marketing
- SNN Industrial Specialties
- Sector
- CHRW Consumer Discretionary
- SNN Health Care
- Exchange
- CHRW Nasdaq
- SNN Nasdaq
- Market Cap
- CHRW 11.6B
- SNN 12.3B
- IPO Year
- CHRW 1997
- SNN 1999
- Fundamental
- Price
- CHRW $101.13
- SNN $28.05
- Analyst Decision
- CHRW Buy
- SNN Hold
- Analyst Count
- CHRW 19
- SNN 3
- Target Price
- CHRW $119.29
- SNN $27.00
- AVG Volume (30 Days)
- CHRW 1.6M
- SNN 744.3K
- Earning Date
- CHRW 04-30-2025
- SNN 02-25-2025
- Dividend Yield
- CHRW 2.45%
- SNN 2.62%
- EPS Growth
- CHRW 41.91
- SNN 56.15
- EPS
- CHRW 3.86
- SNN 0.47
- Revenue
- CHRW $17,724,956,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- CHRW $2.25
- SNN $6.42
- Revenue Next Year
- CHRW $4.65
- SNN $5.03
- P/E Ratio
- CHRW $26.20
- SNN $29.40
- Revenue Growth
- CHRW 0.73
- SNN 4.70
- 52 Week Low
- CHRW $65.00
- SNN $23.65
- 52 Week High
- CHRW $114.82
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- CHRW 53.45
- SNN 48.82
- Support Level
- CHRW $99.31
- SNN $27.83
- Resistance Level
- CHRW $102.93
- SNN $28.71
- Average True Range (ATR)
- CHRW 2.23
- SNN 0.43
- MACD
- CHRW 0.37
- SNN -0.21
- Stochastic Oscillator
- CHRW 77.07
- SNN 10.14
About CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 61% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (27%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.